AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 21 min read$TWFG

DOAK MICHAEL purchased $637K of TWFG (indirect holdings)

DOAK MICHAEL purchased 33,000 indirectly-held shares of TWFG, Inc. (TWFG) at an average of $19.29 ($19.25–$19.33, $0.64M total) across 2 trades over 2026-06-01 to 2026-06-02.

Original reporting
SEC EDGAR · DOAK MICHAEL
Published Jun 2, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TWFG
Bullish
medium confidence
Mentioned
$TWFG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TWFGBullishLow
01

Why it matters

The filing provides fresh data on insider sentiment, which can influence short-term trading decisions.

02

Market read

Direct insider purchase adds modest positive sentiment for TWFG, with limited broader market effect.

03

What to watch

Potential upcoming earnings or regulatory developments not disclosed could be driving the trade.

Relevance 6/10Novelty 6/10Timing: post-market today

Background

Form 4 filings disclose insider transactions; director purchases are monitored for sentiment cues.

Company-level read

Ticker impact

$TWFGBullishMedium confidence
Context

Director Michael Doak purchased 33,000 shares of TWFG for $637K via a Form 4 filing.

Expected impact

likely upward pressure as the market prices in the insider purchase

Evidence & confidence

The purchase size is modest but notable for a director; such trades often lead to modest price appreciation.

Market effects

Sector

May provide a slight bullish cue for the insurance sector if other directors follow suit.

Regional

Limited to U.S. markets where TWFG trades.

Global

Minimal global impact; confined to investors tracking TWFG.

Counterpoint

What could challenge this read

The purchase could be a routine portfolio rebalancing rather than a confidence signal.

Key entities

  • Company
    TWFG, Inc.

    U.S.-listed insurance provider (NASDAQ: TWFG).

  • Individual
    Michael Doak

    Director of TWFG who executed the purchase.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TWFG insider trading history →

Related articles

AUG 14
$TWFGMedAI 8/10

TWFG (TWFG) Q2 2026 Earnings Call Transcript

TWFG’s Q2 2026 earnings call said auto rates are moderating, homeowners rates are flat with some catastrophe-region pressure, and carrier demand for quality independent agents remains strong. TWFG completed the Fortress Insurance Services acquisition on May 1 and is nearing completion of a $50m share repurchase, buying $42.9m at $19/share. Q2 written premium rose 26.6% to $569.9m, net income to $17.3m, adjusted EPS to $0.38.

yahoo.com7 min
AUG 6
$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

insurancebusinessmag.com9 min
AUG 5
$TWFGMed

TWFG Announces Second Quarter 2026 Results

TWFG, Inc. (TWFG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TWFG Announces Second Quarter 2026 Results – Total Revenues increased 45.1% for the quarter over the prior year period to $87.5 million – – Organic Revenue Growth Rate* of 37.0% for the quarter – – Net income of $17.3 million and Net Income Margin of 19.7% for the quarter – – Adj

SEC EDGAR 8-K4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min